Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2012

Aug 21, 2012

30786_dirs_2012-08-21_428806d7-4da3-4158-9ba0-0cf06354c0c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2012-08-20

Reporting Person: CRUTCHFIELD BRADFORD (Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-20 Bio-Rad A Common Stock M 4000 $35.50 Acquired 9875 Direct
2012-08-20 Bio-Rad A Common Stock S 4000 $103.1096 Disposed 5875 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-20 Incentive Stock Option (right to buy) $35.50 M 2870 Disposed 2013-02-05 Bio-Rad A Common Stock (2870) Direct
2012-08-20 Non-Qualified Stock Option (right to buy) $35.50 M 1130 Disposed 2013-02-05 Bio-Rad A Common Stock (1130) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.282 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The option vested in five equal annual installments beginning on February 6, 2003.